STM Journals Peer-reviewed research from Consortium e-Learning Network

International Journal of Cell Biology and Cellular Functions Case Study

Hidradenocarcinoma: A Rare Skin Disease

  1. Aanchal Bhatia Department of Agricultural Biotechnology, Punjab Agricultural University (PAU), Ludhiana
  2. Muskan Tiwari Department of Agricultural Biotechnology, Punjab Agricultural University (PAU), Ludhiana
  3. Gaganpreet Kaur Department of Agricultural Biotechnology, Punjab Agricultural University (PAU), Ludhiana

Abstract

Hidradenocarcinoma (HAC) also known as ‘‘sweat gland tumor” is an aggressive, uncommon, highly malignant, adnexal tumor derived from the intradermal duct of eccrine sweat glands. It is said to be aggressive as it has a high risk of local recurrence (50%–75%) and a high potential to metastasize to nearby lymph nodes or to other distant sites. Hidradenocarcinoma has other recognized variants which are known by different names such as Malignant Acrospiroma, Nodular Hidradenocarcinoma, Clear cell Hidradenocarcinoma, Malignant Nodular Hidradenoma, Malignant Clear Cell Hidradenoma, clear cell eccrine carcinoma or simply sweat gland tumor. However, the term Hidradenocarcinoma (HAC) is the recommended name. This malignant tumor arises from the eccrine glands which are located in sun-exposed locations. These malignancies exhibit a high reactivity to eccrine enzymatic stains and their morphologic features are seen under the electron microscope, so that’s why they are known to originate in the sweat glands. The occurrence rate is about 0.001% of all malignant tumors and Hidradenocarcinoma accounts for approximately 6% of malignant eccrine tumors, which in turn are found in 1:13,000 skin biopsies and <0.001% of all skin cancers. They usually appear de novo on healthy skin, or sometimes malignant transformation from their benign form. In 1865, French pathologist Victor Andre Cornil described the first case of sweat gland cancer. Hidradenocarcinoma (HAC) was first reported in 1948 in Brazil and was first described as a clear cell eccrine carcinoma by Keasby and Hadley in 1954. When Keasby first described this tumor in 1954 he found only 3 cases of hidradenocarcinoma among 235 sweat gland tumors.

Keywords

References (34)

  1. Kane B, Adler E, Bhandari T, Rose M, DiGuglielmo N, Sun X. Malignant Hidradenocarcinoma in the Lower Extremity: A Case Report of a Rare Tumor. The Journal of Foot and Ankle Surgery. 2018;57(3):618-621. doi:10.1053/j.jfas.2017.10.024
  2. Mackenzie DH. A clear-cell hidradenocarcinoma with metastases. Cancer. 1957;10:1021–3. doi:10.1002/1097-0142(195709/10)10:53.0.co;2-q, PubMed: 13472651.
  3. Ryu WC, Lee YH, Koh IC, Sohn JS, Jang SM. Hidradenocarcinoma of the Dorsum of the Hand. Chinese Medical Journal. 2017;130(14):1755-1756. doi:10.4103/0366-6999.209899
  4. Singh R, Brewer J, Bernstein ZP, Higgs D. No Sweat, a Rare Case of Hidradenocarcinoma. The American Surgeon™. 2012;78(2):92-93. doi:10.1177/000313481207800218
  5. Lim J, Park SY, Lew H, Cho K. Hidradenocarcinoma on the Orbit. The Nerve. 2018;4(1):16-19. doi:10.21129/nerve.2018.4.1.16
  6. Singh G, Narasimha A, Kumar H, Datti N. Clear cell hidradenocarcinoma of the eyelid: a case report with a review of the literature. International Ophthalmology. 2012;33(2):171-175. doi:10.1007/s10792-012-9645-y
  7. Farooq U, Choudhary S, Russo J, Vincek V, Elgart G. Clear cell hidradenocarcinoma with helpful immunohistochemistry: a case report. International Journal of Dermatology. 2012;52(11):1380-1382. doi:10.1111/j.1365-4632.2011.05433.x
  8. Nazarian RM, Kapur P, Rakheja D, Piris A, Duncan LM, Mihm MC, et al. Atypical and malignant hidradenomas: a histological and immunohistochemical study. Modern Pathology. 2009;22(4):600-610. doi:10.1038/modpathol.2009.18
  9. Ko CJ, Cochran AJ, Eng W, Binder SW. Hidradenocarcinoma: a histological and immunohistochemical study*. Journal of Cutaneous Pathology. 2006;33(11):726-730. doi:10.1111/j.1600-0560.2006.00536.x
  10. Gupta E, Guthrie KJ, Krishna M, Asmann Y, Parker AS, Joseph RW. Whole Exome Sequencing of a Patient with Metastatic Hidradenocarcinoma and Review of the Literature. Rare Tumors. 2015;7(1):29-33. doi:10.4081/rt.2015.5719
  11. Latorre A, Alghothani L, Lambert D, Jatana KR, Peters S, Foster J, Hill R. Mucin-producing malignant tumor of lower eyelid presenting in a 14-year-old patient. J Clin Aesthet Dermatol. 2012;5:44–7. PubMed: 22708009.
  12. Nongkynrih A, Kamboj K, Dhull AK, Kaushal V. Miraculous response to radiotherapy in a rare case of malignant nodular hidradenoma nose. J Cancer Prev Curr Res. 2018;9:97–9.
  13. Wiedemeyer K, Brenn T. Malignant Skin Adnexal Tumors: Pathology and Genetics. Reference Module in Biomedical Sciences. 2018. doi:10.1016/b978-0-12-801238-3.65096-1
  14. KERSTING DW. Clear Cell Hidradenoma and Hidradenocarcinoma. Archives of Dermatology. 1963;87(3):323. doi:10.1001/archderm.1963.01590150039007
  15. Patel N, Kramer A, Sun X. A Case of Clear Cell Hidradenoma Found During Abdominal Cyst Excision. Cureus. 2022. doi:10.7759/cureus.22957
  16. Ham T, Cheon SJ, Roh MS, Ha DH. Ultrasonography of Malignant Clear Cell Hidradenoma: A Case Report. Journal of the Korean Society of Radiology. 2020;81(2):448. doi:10.3348/jksr.2020.81.2.448
  17. Ahn CS, Sangüeza OP. Malignant Sweat Gland Tumors. Hematology/Oncology Clinics of North America. 2019;33(1):53-71. doi:10.1016/j.hoc.2018.09.002
  18. Baklacı D, Kum RO, Yilmaz Y, Özcan M, Ünal A. An unusual tumor of the lower lip: Benign nodular hidradenoma. Entomologist. 2017.
  19. Kazakov DV, Ivan D, Kutzner H, Spagnolo DV, Grossmann P, Vanecek T, et al. Cutaneous Hidradenocarcinoma: A Clinicopathological, Immunohistochemical, and Molecular Biologic Study of 14 Cases, Including Her2/neu Gene Expression/Amplification, TP53 Gene Mutation Analysis, and t(11;19) Translocation. The American Journal of Dermatopathology. 2009;31(3):236-247. doi:10.1097/dad.0b013e3181984f10
  20. Driscoll JJ, Gauerke S, Monahan BC. Mechanistic and Treatment Implications of ΔNp63 Expression in a Rare Case of Metastatic Hidradenocarcinoma. Case Reports in Oncology. 2009;2(1):44-52. doi:10.1159/000205351
  21. An JK, Woo JJ, Hong YO. Malignant sweat gland tumor of breast arising in pre-existing benign tumor: A case report. World Journal of Clinical Cases. 2019;7(19):3033-3038. doi:10.12998/wjcc.v7.i19.3033
  22. Martins D, Pereira F, Azevedo R, Julião I. Eccrine Hidradenocarcinoma of the Scalp. Cureus. 2022. doi:10.7759/cureus.23023
  23. Mir Khan B, Mansha MA, Ali N, Abbasi ANN, Ahmed SM, Qureshi BM. Hidradenocarcinoma: Five Years of Local and Systemic Control of a Rare Sweat Gland Neoplasm with Nodal Metastasis. Cureus. 2018. doi:10.7759/cureus.2884
  24. Sanders DSA, Carr RA. The use of immunohistochemistry in the differential diagnosis of common epithelial tumours of the skin. Curr Diagn Pathol. 2007;13(3):237–51. doi:10.1016/j.cdip.2007.
  25. Soni A, Bansal N, Kaushal V, Chauhan AK. Current management approach to hidradenocarcinoma: A comprehensive review of the literature. Ecancermedicalscience. 2015;9:517. DOI: 10.3332/
  26. ecancer.2015.517, PubMed: 25815059.
  27. Cleaveland P, Srivastava P, Oliveira P, Parnham A, Elliott T, Sangar V. A rare presentation of hidradenocarcinoma within the penis. Urology Case Reports. 2019;22:57-59. doi:10.1016/j.eucr.2018.10.016
  28. Ohta M, Hiramoto M, Fujii M, Togo T. Nodular Hidradenocarcinoma on the Scalp of a Young Woman: Case Report and Review of Literature. Dermatologic Surgery. 2004;30(9):1265-1268. doi:10.1111/j.1524-4725.2004.30390.x
  29. Elbenaye J, Moumine M, Sinaa M, Elhaouri M. Fatal hidradenocarcinoma of the scalp: A case report. European Annals of Otorhinolaryngology, Head and Neck Diseases. 2017;134(4):291-292. doi:10.1016/j.anorl.2017.03.008
  30. Holden B, Colome-Grimmer M, Savage C, Stierman K, Pou AM. Malignant Eccrine Acrospiroma with Metastasis to the Parotid. Ear, Nose & Throat Journal. 2002;81(5):352-355. doi:10.1177/014556130208100515
  31. Son ET, Choi HJ, Lee HJ. Case report: clear cell hidradenocarcinoma of the nail bed. International Wound Journal. 2015;13(5):1067-1069. doi:10.1111/iwj.12482
  32. Dillon C, Sevensma K, Morgan W. Treatment of hidradenocarcinoma of the scalp with wide local excision: Case report of a rare and malignant tumor. Ann Clin Case Rep. 2019;4:1746.
  33. Stanciu A, Florica Turcu CE, Zota A, Tebeica T, Leventer M, Bobirca F. Surgical Outcomes of More Than 1300 Cases of Mohs Micrographic Surgeries from a Private Mohs Clinic in Romania. Chirurgia. 2020;115(1):69. doi:10.21614/chirurgia.115.1.69
  34. Bedada AG, Georges A, Eshetu AB. Perianal malignant nodular hidradenoma in HIV infected pregnant patient. South African Journal of Surgery. 2018;56(2):64-66. doi:10.17159/2078-5151/2018/v56n2a2516